News About: Pharm. Industry
Ketotop tops brand rankings
Pacific Pharm beat pharmaceutical companies by large margins to be named as the best medicinal patch in Korea for the six consecutive year, according to a local survey.
The Korean Management Association (KMA) annou...
Adalat Oros differs from general products in pharmacokinetic profiles, BayerSchering HealthCare says
All once-daily nifedipine formulations are not pharmacokinetically the same, according to clinical data released by BayerSchering HealthCare on March 3.
Citing the theses published by British Journal of Clinical Ph...
Data fabrication of nifedipine sparks debate
BayerSchering HealthCare's claim that local nipedipine makers fabricated bioequivalence test data due to technical limitation in plasma concentrations of nifedipine for at lease 24 hours is groundless, according to Ph...
Wholesaler margins thinner
Drug wholesalers have seen their wholesaler margins worsening as some pharmaceutical makers have implemented new sales policy to shorten their money collection period.
For example, ethical associate wholesalers of ...
Huons to build W40 billion GMP plant
Huons, local pharmaceutical maker, says it will invest 40 billion won to build a plant producing drug products for its exports to advanced countries, including United States.
The plant will be created at Jaecheon o...
Korea's pharmaceutical exports top $1.46 billion in 2007
The country's total drug exports to 147 countries, including pharmaceutical bulks, finished drug products, quasi-drug, cosmetics and oriental medicines, stood at $1.46 billion in 2007, according to the Korea Pharmaceu...
Bayer Korea's tighter money payment policy angers drug wholesalers
Ethical wholesalers made clear their opposition of Bayer Korea's new 90-day turnover plan with 100% collateral which has been implemented from this month.
According to the plan, ethical associate wholesalers are ob...
Immunosuppressant Tacrobell is effective and safe in adult liver transplantation
Combination therapy of Tacrobell (taclolimus) capsule and basiliximab or mycophenolate mofetil has been shown to be effective for the prevention and treatment of allograft rejection in liver transplantation, according...
Government to back 6 platform technologiesThe government plans to assist six core platform technologies this year as part of its efforts to enhance Korea's research and development capabilities for new drug, according t...
|
Drug makers seeks market expansion to 2 trillion won by 2012The Korea Pharmaceutical Manufacturers Association has unveiled its long-term plan to expand the domestic pharmaceutical market to 2 trillion won until 2012, by increasing its s...
|
